Hypertension: RAS blockade, hyperkalemia and AKI-look and you will find

Research output: Contribution to journalArticle

4 Scopus citations

Abstract

Aliskiren combined with other inhibitors of the renin-angiotensin system increases the risk of hyperkalemia. This risk does not translate into an increased incidence of acute kidney injury, suggest the results of a meta-analysis. However, further research is needed to fully evaluate the safety of combination therapy with aliskiren.

Original languageEnglish (US)
Pages (from-to)257-258
Number of pages2
JournalNature Reviews Nephrology
Volume8
Issue number5
DOIs
StatePublished - May 1 2012

ASJC Scopus subject areas

  • Nephrology

Fingerprint Dive into the research topics of 'Hypertension: RAS blockade, hyperkalemia and AKI-look and you will find'. Together they form a unique fingerprint.

  • Cite this